Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Phase 1
Terminated
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Saline PlaceboDrug: NCTX (PEGylated Liposomal Iodixanol Injection)
- First Posted Date
- 2014-02-14
- Last Posted Date
- 2014-10-10
- Lead Sponsor
- Marval Pharma Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02063594
- Locations
- 🇺🇸
Quintiles Phase 1 Services, Overland Park, Kansas, United States
News
No news found